{
    "abstract": "Background Immunization with pneumococcal vaccines is an important prophylactic strategy for children with asplenia or splenic dysfunction, who are at high risk of bacterial infections (including S. pneumoniae). This study aimed to assess immunogenicity and safety of pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV, GSK) in this at-risk population. Methods This phase III, multi-centre, open-label, controlled study, in which at-risk children with asplenia or splenic dysfunction were enrolled (age strata: 2\u20134, 5\u201310 and 11\u201317 years), was conducted in Poland and the Russian Federation. For the 2\u20134 years at-risk group, healthy age-matched children were enrolled as control. Unprimed children (not previously vaccinated with any pneumococcal vaccine) received 2 PHiD-CV doses (\u22652 months apart) and pneumococcal vaccine-primed children received 1 dose. Immune responses were assessed pre-vaccination and one month post-each dose. Solicited and unsolicited adverse events (AEs) were recorded for 4 and 31 days post-vaccination, respectively, and serious AEs (SAEs) throughout the study. Results Of 52 vaccinated children (18 at-risk primed, 28 at-risk unprimed and 6 control unprimed), 45 (18, 23 and 4, respectively) were included in the according-to-protocol cohort for immunogenicity. Post-vaccination (post-dose 1 in primed and post-dose 2 in unprimed children), for each vaccine pneumococcal serotype and vaccine-related serotype 6A all at-risk children had antibody concentrations \u22650.2 \u00b5g/mL, and for vaccine-related serotype 19A at least 94.4%. Increases in antibody geometric mean concentrations were observed. For most serotypes, all at-risk children had post-vaccination opsonophagocytic activity (OPA) titers \u22658 and increases in OPA geometric mean titers were observed. No safety concerns were raised. One non-fatal SAE (respiratory tract infection, considered not vaccine-related) was reported by one at-risk unprimed child. Conclusion PHiD-CV was immunogenic and well tolerated in 2\u201317-year-old children with asplenia or splenic dysfunction. Clinical Trial Registry: www.clinicaltrials.gov, NCT01746108.",
    "author_highlights": [
        {
            "endOffset": 20078,
            "sentence": "Immunogenicity and safety of PHiD-CV was studied in 2\u201317-year-old at-risk children.",
            "startOffset": 19995
        },
        {
            "endOffset": 20161,
            "sentence": "46 children with asplenia or splenic dysfunction received 1 or 2 doses of PHiD-CV.",
            "startOffset": 20079
        },
        {
            "endOffset": 20245,
            "sentence": "PHiD-CV was immunogenic in at-risk children and no safety concerns were identified.",
            "startOffset": 20162
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Ram"
                },
                {
                    "first": "Lisa A.",
                    "initial": "L.A.",
                    "last": "Lewis"
                },
                {
                    "first": "Peter A.",
                    "initial": "P.A.",
                    "last": "Rice"
                }
            ],
            "doi": "10.1128/CMR.00048-09",
            "firstpage": "740",
            "issn": "08938512",
            "lastpage": "780",
            "pmid": "20930072",
            "pub_year": 2010,
            "title": "Infections of people with complement deficiencies and patients who have undergone splenectomy",
            "volume": "23"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Elio",
                    "initial": "E.",
                    "last": "Castagnola"
                },
                {
                    "first": "Francesca",
                    "initial": "F.",
                    "last": "Fioredda"
                }
            ],
            "doi": "10.1034/j.1600-0609.2003.00158.x",
            "firstpage": "319",
            "issn": "09024441",
            "lastpage": "326",
            "pmid": "14667194",
            "pub_year": 2003,
            "title": "Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: A brief review of current recommendations for practical purposes",
            "volume": "71"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Thomas V.",
                    "initial": "T.V.",
                    "last": "Adamkiewicz"
                },
                {
                    "first": "Sharada",
                    "initial": "S.",
                    "last": "Sarnaik"
                },
                {
                    "first": "George R.",
                    "initial": "G.R.",
                    "last": "Buchanan"
                },
                {
                    "first": "Rathi V.",
                    "initial": "R.V.",
                    "last": "Iyer"
                },
                {
                    "first": "Scott T.",
                    "initial": "S.T.",
                    "last": "Miller"
                },
                {
                    "first": "Charles H.",
                    "initial": "C.H.",
                    "last": "Pegelow"
                },
                {
                    "first": "Zora R.",
                    "initial": "Z.R.",
                    "last": "Rogers"
                },
                {
                    "first": "Elliott",
                    "initial": "E.",
                    "last": "Vichinsky"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Elliott"
                },
                {
                    "first": "Richard R.",
                    "initial": "R.R.",
                    "last": "Facklam"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Benjamin",
                    "initial": "B.",
                    "last": "Schwartz"
                },
                {
                    "first": "Chris A.",
                    "initial": "C.A.",
                    "last": "Van Beneden"
                },
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "Cannon"
                },
                {
                    "first": "James R.",
                    "initial": "J.R.",
                    "last": "Eckman"
                },
                {
                    "first": "Harry",
                    "initial": "H.",
                    "last": "Keyserling"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Sullivan"
                },
                {
                    "first": "Wing Yen",
                    "initial": "W.Y.",
                    "last": "Wong"
                },
                {
                    "first": "Winfred C.",
                    "initial": "W.C.",
                    "last": "Wang"
                }
            ],
            "doi": "10.1067/S0022-3476(03)00331-7",
            "firstpage": "438",
            "issn": "00223476",
            "lastpage": "444",
            "pmid": "14571216",
            "pub_year": 2003,
            "title": "Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination",
            "volume": "143"
        },
        "b0020": {
            "authors": [
                {
                    "first": "E. G.",
                    "initial": "E.G.",
                    "last": "Mourtzoukou"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Pappas"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Peppas"
                },
                {
                    "first": "M. E.",
                    "initial": "M.E.",
                    "last": "Falagas"
                }
            ],
            "doi": "10.1002/bjs.6106",
            "firstpage": "273",
            "issn": "00071323",
            "lastpage": "280",
            "pmid": "18278784",
            "pub_year": 2008,
            "title": "Vaccination of asplenic or hyposplenic adults",
            "volume": "95"
        },
        "b0025": {
            "authors": [
                {
                    "first": "J. Pekka",
                    "initial": "J.P.",
                    "last": "Nuorti"
                },
                {
                    "first": "Cynthia G.",
                    "initial": "C.G.",
                    "last": "Whitney"
                }
            ],
            "firstpage": "1",
            "issn": "01492195",
            "lastpage": "19",
            "pmid": "21150868",
            "pub_year": 2010,
            "title": "Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine recommendations of the advisory committee on immunization practices (acip)",
            "volume": "59"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Elizabeth A.",
                    "initial": "E.A.",
                    "last": "Clutterbuck"
                },
                {
                    "first": "Rajeka",
                    "initial": "R.",
                    "last": "Lazarus"
                },
                {
                    "first": "Ly Mee",
                    "initial": "L.M.",
                    "last": "Yu"
                },
                {
                    "first": "Jaclyn",
                    "initial": "J.",
                    "last": "Bowman"
                },
                {
                    "first": "Elizabeth A.L.",
                    "initial": "E.A.L.",
                    "last": "Bateman"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Diggle"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Angus"
                },
                {
                    "first": "Tim E.",
                    "initial": "T.E.",
                    "last": "Peto"
                },
                {
                    "first": "Peter C.",
                    "initial": "P.C.",
                    "last": "Beverley"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Mant"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1093/infdis/jis212",
            "firstpage": "1408",
            "issn": "00221899",
            "lastpage": "1416",
            "pmid": "22457293",
            "pub_year": 2012,
            "title": "Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells",
            "volume": "205"
        },
        "b0035": null,
        "b0040": {
            "authors": [
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Andrea J.",
                    "initial": "A.J.",
                    "last": "Swift"
                },
                {
                    "first": "Jerry A.",
                    "initial": "J.A.",
                    "last": "Winkelstein"
                },
                {
                    "first": "Mathuram",
                    "initial": "M.",
                    "last": "Santosham"
                },
                {
                    "first": "Beth",
                    "initial": "B.",
                    "last": "Stover"
                },
                {
                    "first": "Ruth",
                    "initial": "R.",
                    "last": "Luddy"
                },
                {
                    "first": "Joseph E.",
                    "initial": "J.E.",
                    "last": "Gootenberg"
                },
                {
                    "first": "Jeffrey T.",
                    "initial": "J.T.",
                    "last": "Nold"
                },
                {
                    "first": "Allen",
                    "initial": "A.",
                    "last": "Eskenazi"
                },
                {
                    "first": "Sally J.",
                    "initial": "S.J.",
                    "last": "Snader"
                },
                {
                    "first": "Howard M.",
                    "initial": "H.M.",
                    "last": "Lederman"
                }
            ],
            "doi": "10.1542/peds.106.5.965",
            "firstpage": "965",
            "issn": "00314005",
            "lastpage": "972",
            "pmid": "11061761",
            "pub_year": 2000,
            "title": "Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 among infants with sickle cell disease",
            "volume": "106"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Reinert"
                },
                {
                    "first": "Malika",
                    "initial": "M.",
                    "last": "Benkerrou"
                },
                {
                    "first": "Mariane",
                    "initial": "M.",
                    "last": "De Montalembert"
                },
                {
                    "first": "Emmanuelle",
                    "initial": "E.",
                    "last": "Lesprit"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Abadie"
                },
                {
                    "first": "Fran\u00e7oise",
                    "initial": "F.",
                    "last": "Bernaudin"
                },
                {
                    "first": "Catherine",
                    "initial": "C.",
                    "last": "Doit"
                },
                {
                    "first": "Edouard",
                    "initial": "E.",
                    "last": "Bingen"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Tetelboum"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Bonnet"
                }
            ],
            "doi": "10.1097/INF.0b013e31814614c6",
            "firstpage": "1105",
            "issn": "08913668",
            "lastpage": "1109",
            "pmid": "18043446",
            "pub_year": 2007,
            "title": "Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease",
            "volume": "26"
        },
        "b0050": {
            "authors": [
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Smets"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Bourgois"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Vermylen"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Brichard"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Slacmuylders"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Leyman"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Sokal"
                }
            ],
            "doi": "10.1016/j.vaccine.2007.05.014",
            "firstpage": "5278",
            "issn": "0264410X",
            "lastpage": "5282",
            "pmid": "17576024",
            "pub_year": 2007,
            "title": "Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine",
            "volume": "25"
        },
        "b0055": {
            "authors": [
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Mikoluc"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Kayhty"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Bernatowska"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Motkowski"
                }
            ],
            "doi": "10.1007/s10096-008-0523-5",
            "firstpage": "923",
            "issn": "09349723",
            "lastpage": "928",
            "pmid": "18584224",
            "pub_year": 2008,
            "title": "Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children",
            "volume": "27"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Mariane",
                    "initial": "M.",
                    "last": "De Montalembert"
                },
                {
                    "first": "Miguel R.",
                    "initial": "M.R.",
                    "last": "Abboud"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Fiquet"
                },
                {
                    "first": "Adlette",
                    "initial": "A.",
                    "last": "Inati"
                },
                {
                    "first": "Jeffrey D.",
                    "initial": "J.D.",
                    "last": "Lebensburger"
                },
                {
                    "first": "Normeen",
                    "initial": "N.",
                    "last": "Kaddah"
                },
                {
                    "first": "Galila",
                    "initial": "G.",
                    "last": "Mokhtar"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Piga"
                },
                {
                    "first": "Natasha",
                    "initial": "N.",
                    "last": "Halasa"
                },
                {
                    "first": "Baba",
                    "initial": "B.",
                    "last": "Inusa"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Rees"
                },
                {
                    "first": "Paul T.",
                    "initial": "P.T.",
                    "last": "Heath"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Telfer"
                },
                {
                    "first": "Catherine",
                    "initial": "C.",
                    "last": "Driscoll"
                },
                {
                    "first": "Sami",
                    "initial": "S.",
                    "last": "Al Hajjar"
                },
                {
                    "first": "Alberto",
                    "initial": "A.",
                    "last": "Tozzi"
                },
                {
                    "first": "Qin",
                    "initial": "Q.",
                    "last": "Jiang"
                },
                {
                    "first": "Emilio A.",
                    "initial": "E.A.",
                    "last": "Emini"
                },
                {
                    "first": "William C.",
                    "initial": "W.C.",
                    "last": "Gruber"
                },
                {
                    "first": "Alejandra",
                    "initial": "A.",
                    "last": "Gurtman"
                },
                {
                    "first": "Daniel A.",
                    "initial": "D.A.",
                    "last": "Scott"
                }
            ],
            "doi": "10.1002/pbc.25502",
            "firstpage": "1427",
            "issn": "15455009",
            "lastpage": "1436",
            "pmid": "25810327",
            "pub_year": 2015,
            "title": "13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study",
            "volume": "62"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1586/erv.09.113",
            "firstpage": "1479",
            "issn": "14760584",
            "lastpage": "1500",
            "pmid": "19863240",
            "pub_year": 2009,
            "title": "10-Valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix\u2122",
            "volume": "8"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Miguel W.",
                    "initial": "M.W.",
                    "last": "Tregnaghi"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "S\u00e1ez-Llorens"
                },
                {
                    "first": "Pio",
                    "initial": "P.",
                    "last": "L\u00f3pez"
                },
                {
                    "first": "Hector",
                    "initial": "H.",
                    "last": "Abate"
                },
                {
                    "first": "Enrique",
                    "initial": "E.",
                    "last": "Smith"
                },
                {
                    "first": "Adriana",
                    "initial": "A.",
                    "last": "P\u00f3sleman"
                },
                {
                    "first": "Arlene",
                    "initial": "A.",
                    "last": "Calvo"
                },
                {
                    "first": "Digna",
                    "initial": "D.",
                    "last": "Wong"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Cortes-Barbosa"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Ceballos"
                },
                {
                    "first": "Marcelo",
                    "initial": "M.",
                    "last": "Tregnaghi"
                },
                {
                    "first": "Alexandra",
                    "initial": "A.",
                    "last": "Sierra"
                },
                {
                    "first": "Mirna",
                    "initial": "M.",
                    "last": "Rodriguez"
                },
                {
                    "first": "Marisol",
                    "initial": "M.",
                    "last": "Troiti\u00f1o"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Carabajal"
                },
                {
                    "first": "Andrea",
                    "initial": "A.",
                    "last": "Falaschi"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Leandro"
                },
                {
                    "first": "Maria Mercedes",
                    "initial": "M.M.",
                    "last": "Castrej\u00f3n"
                },
                {
                    "first": "Alejandro",
                    "initial": "A.",
                    "last": "Lepetic"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Lommel"
                },
                {
                    "first": "William P.",
                    "initial": "W.P.",
                    "last": "Hausdorff"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                },
                {
                    "first": "Javier Ruiz",
                    "initial": "J.R.",
                    "last": "Gui\u00f1az\u00fa"
                },
                {
                    "first": "Eduardo",
                    "initial": "E.",
                    "last": "Ortega-Barr\u00eda"
                },
                {
                    "first": "Juan P.",
                    "initial": "J.P.",
                    "last": "Yarz\u00e1bal"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1371/journal.pmed.1001657",
            "firstpage": "1",
            "issn": "15491277",
            "lastpage": "18",
            "pmid": "24892763",
            "pub_year": 2014,
            "title": "Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial",
            "volume": "11"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Arto A.",
                    "initial": "A.A.",
                    "last": "Palmu"
                },
                {
                    "first": "Jukka",
                    "initial": "J.",
                    "last": "Jokinen"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                },
                {
                    "first": "Heta",
                    "initial": "H.",
                    "last": "Nieminen"
                },
                {
                    "first": "Esa",
                    "initial": "E.",
                    "last": "Ruokokoski"
                },
                {
                    "first": "Lotta",
                    "initial": "L.",
                    "last": "Siira"
                },
                {
                    "first": "Taneli",
                    "initial": "T.",
                    "last": "Puumalainen"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Lommel"
                },
                {
                    "first": "Marjan",
                    "initial": "M.",
                    "last": "Hezareh"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Moreira"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                },
                {
                    "first": "Terhi M.",
                    "initial": "T.M.",
                    "last": "Kilpi"
                }
            ],
            "doi": "10.1016/S0140-6736(12)61854-6",
            "firstpage": "214",
            "issn": "01406736",
            "lastpage": "222",
            "pub_year": 2013,
            "title": "Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: A cluster randomised trial",
            "volume": "381"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Carla Magda Allan S.",
                    "initial": "C.M.A.S.",
                    "last": "Domingues"
                },
                {
                    "first": "Jennifer R.",
                    "initial": "J.R.",
                    "last": "Verani"
                },
                {
                    "first": "Ernesto Issac",
                    "initial": "E.I.",
                    "last": "Montenegro Renoiner"
                },
                {
                    "first": "Maria Cristina",
                    "initial": "M.C.",
                    "last": "de Cunto Brandileone"
                },
                {
                    "first": "Brendan",
                    "initial": "B.",
                    "last": "Flannery"
                },
                {
                    "first": "Lucia Helena",
                    "initial": "L.H.",
                    "last": "de Oliveira"
                },
                {
                    "first": "Jo\u00e3o Barberino",
                    "initial": "J.B.",
                    "last": "Santos"
                },
                {
                    "first": "Jos\u00e9 C\u00e1ssio",
                    "initial": "J.C.",
                    "last": "de Moraes"
                },
                {
                    "first": "Regina Coeli Magalh\u00e3es",
                    "initial": "R.C.M.",
                    "last": "Rodrigues"
                },
                {
                    "first": "Marluce Aparecida Assun\u00e7\u00e3o",
                    "initial": "M.A.A.",
                    "last": "Oliveira"
                },
                {
                    "first": "Tani Maria Schilling",
                    "initial": "T.M.S.",
                    "last": "Ranieri"
                },
                {
                    "first": "Gladys Maria",
                    "initial": "G.M.",
                    "last": "Zubaran"
                },
                {
                    "first": "Ana L\u00eddia Lima",
                    "initial": "A.L.L.",
                    "last": "Solon"
                },
                {
                    "first": "Maria Iracema",
                    "initial": "M.I.",
                    "last": "de Aguiar Patr\u00edcio"
                },
                {
                    "first": "Maria Elisa Paula",
                    "initial": "M.E.P.",
                    "last": "de Oliveira"
                },
                {
                    "first": "Rita",
                    "initial": "R.",
                    "last": "de C\u00e1ssia Vilasboas Silva"
                },
                {
                    "first": "Marlene Sera",
                    "initial": "M.S.",
                    "last": "Wille"
                },
                {
                    "first": "Pilar Gomes",
                    "initial": "P.G.",
                    "last": "Martinez"
                },
                {
                    "first": "Helena Keico",
                    "initial": "H.K.",
                    "last": "Sato"
                },
                {
                    "first": "Maria Cristina Hereny",
                    "initial": "M.C.H.",
                    "last": "Bordim"
                },
                {
                    "first": "Luzia Auxiliadora",
                    "initial": "L.A.",
                    "last": "Careli"
                },
                {
                    "first": "Vera L\u00facia",
                    "initial": "V.L.",
                    "last": "da Gl\u00f3ria Malheiros"
                },
                {
                    "first": "Zenize Rocha",
                    "initial": "Z.R.",
                    "last": "da Silva Costa"
                },
                {
                    "first": "Maria Goretti Varej\u00e3o",
                    "initial": "M.G.V.",
                    "last": "da Silva"
                },
                {
                    "first": "Cleidiane Santos",
                    "initial": "C.S.",
                    "last": "Rodrigues"
                },
                {
                    "first": "Ataiza C\u00e9sar",
                    "initial": "A.C.",
                    "last": "Vieira"
                },
                {
                    "first": "Lucila Tacac\u00f4",
                    "initial": "L.T.",
                    "last": "Watanabe"
                },
                {
                    "first": "Glaucia Gama Rahal",
                    "initial": "G.G.R.",
                    "last": "Aires"
                },
                {
                    "first": "Robmary Matias",
                    "initial": "R.M.",
                    "last": "de Almeida"
                },
                {
                    "first": "Diana Felicia",
                    "initial": "D.F.",
                    "last": "de Ara\u00fajo Margarido"
                },
                {
                    "first": "Ana L\u00facia Stone",
                    "initial": "A.L.S.",
                    "last": "de Souza"
                },
                {
                    "first": "Samanta C.G.",
                    "initial": "S.C.G.",
                    "last": "Almeida"
                },
                {
                    "first": "Angela P.",
                    "initial": "A.P.",
                    "last": "Brand\u00e3o"
                },
                {
                    "first": "Lincoln S.",
                    "initial": "L.S.",
                    "last": "Prado"
                },
                {
                    "first": "Maria Luiza L.S.",
                    "initial": "M.L.L.S.",
                    "last": "Guerra"
                },
                {
                    "first": "Orlando Cesar",
                    "initial": "O.C.",
                    "last": "Mantese"
                },
                {
                    "first": "Eitan",
                    "initial": "E.",
                    "last": "Berezin"
                },
                {
                    "first": "Cicero",
                    "initial": "C.",
                    "last": "Dias"
                },
                {
                    "first": "Cristiana",
                    "initial": "C.",
                    "last": "Nascimento"
                },
                {
                    "first": "Joice",
                    "initial": "J.",
                    "last": "Reis"
                },
                {
                    "first": "Ana Lucia",
                    "initial": "A.L.",
                    "last": "Andrade"
                },
                {
                    "first": "Solange",
                    "initial": "S.",
                    "last": "Andrade"
                },
                {
                    "first": "Flavia",
                    "initial": "F.",
                    "last": "Lobo"
                },
                {
                    "first": "Camile",
                    "initial": "C.",
                    "last": "de Moraes"
                },
                {
                    "first": "Eliane Castro",
                    "initial": "E.C.",
                    "last": "de Barros"
                },
                {
                    "first": "M\u00e1rcia Lopes",
                    "initial": "M.L.",
                    "last": "de Carvalho"
                },
                {
                    "first": "Elias Duarte Gon\u00e7alves",
                    "initial": "E.D.G.",
                    "last": "Correia"
                },
                {
                    "first": "Selma Lina",
                    "initial": "S.L.",
                    "last": "Suzuki"
                }
            ],
            "doi": "10.1016/S2213-2600(14)70060-8",
            "firstpage": "464",
            "issn": "22132600",
            "lastpage": "471",
            "pmid": "24726406",
            "pub_year": 2014,
            "title": "Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: A matched case-control study",
            "volume": "2"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Jennifer R.",
                    "initial": "J.R.",
                    "last": "Verani"
                },
                {
                    "first": "Carla Magda A.Santos",
                    "initial": "C.M.A.S.",
                    "last": "Domingues"
                },
                {
                    "first": "Jos\u00e9 Cassio de",
                    "initial": "J.C.d.",
                    "last": "Moraes"
                },
                {
                    "first": "Ernesto Renoiner",
                    "initial": "E.R.",
                    "last": "Montenegro"
                },
                {
                    "first": "Maria Cristina",
                    "initial": "M.C.",
                    "last": "de Cunto Brandileone"
                },
                {
                    "first": "Brendan",
                    "initial": "B.",
                    "last": "Flannery"
                },
                {
                    "first": "L\u00facia Helena",
                    "initial": "L.H.",
                    "last": "de Oliveira"
                },
                {
                    "first": "Jo\u00e3o Barberino",
                    "initial": "J.B.",
                    "last": "dos Santo Regina Coeli"
                },
                {
                    "first": "Magalh\u00e3es",
                    "initial": "M.",
                    "last": "Rodrigues"
                },
                {
                    "first": "Marluce Aparecida Assun\u00e7\u00e3o",
                    "initial": "M.A.A.",
                    "last": "Oliveira"
                },
                {
                    "first": "Tani Maria Schilling",
                    "initial": "T.M.S.",
                    "last": "Ranieri"
                },
                {
                    "first": "Gladys Maria",
                    "initial": "G.M.",
                    "last": "Zubaran"
                },
                {
                    "first": "Ana L\u00eddia Lima",
                    "initial": "A.L.L.",
                    "last": "Solon"
                },
                {
                    "first": "Maria Iracema",
                    "initial": "M.I.",
                    "last": "de Aguiar Patr\u00edcio"
                },
                {
                    "first": "Maria Elisa Paula",
                    "initial": "M.E.P.",
                    "last": "de Oliveira"
                },
                {
                    "first": "Rita",
                    "initial": "R.",
                    "last": "de C\u00e1ssia Vilasboas Silva"
                },
                {
                    "first": "Marlene Sera",
                    "initial": "M.S.",
                    "last": "Wille"
                },
                {
                    "first": "Pilar Gomes",
                    "initial": "P.G.",
                    "last": "Martinez"
                },
                {
                    "first": "Helena Keico",
                    "initial": "H.K.",
                    "last": "Sato"
                },
                {
                    "first": "Maria Cristina Hereny",
                    "initial": "M.C.H.",
                    "last": "Bordim"
                },
                {
                    "first": "Luzia Aux Iliadora",
                    "initial": "L.A.I.",
                    "last": "Careli"
                },
                {
                    "first": "Vera L\u00facia",
                    "initial": "V.L.",
                    "last": "da Gl\u00f3ria Malheiros"
                },
                {
                    "first": "Zenize Rocha",
                    "initial": "Z.R.",
                    "last": "da Silva Costa"
                },
                {
                    "first": "Maria Goretti Varej\u00e3o",
                    "initial": "M.G.V.",
                    "last": "da Silva"
                },
                {
                    "first": "Cleidiane Santos",
                    "initial": "C.S.",
                    "last": "Rodrigues"
                },
                {
                    "first": "Ataiza C\u00e9sar",
                    "initial": "A.C.",
                    "last": "Vieira"
                },
                {
                    "first": "Lucila Tacac\u00f4",
                    "initial": "L.T.",
                    "last": "Watanabe"
                },
                {
                    "first": "Glaucia Gama Rahal",
                    "initial": "G.G.R.",
                    "last": "Aires"
                },
                {
                    "first": "Robmary Matias",
                    "initial": "R.M.",
                    "last": "de Almeida"
                },
                {
                    "first": "Diana Felicia",
                    "initial": "D.F.",
                    "last": "de Ara\u00fajo Margarido"
                },
                {
                    "first": "Ana L\u00facia Stone",
                    "initial": "A.L.S.",
                    "last": "de Souza"
                },
                {
                    "first": "Samanta C.G.",
                    "initial": "S.C.G.",
                    "last": "Almeida"
                },
                {
                    "first": "Angela P.",
                    "initial": "A.P.",
                    "last": "Brand\u00e3o"
                },
                {
                    "first": "Lincoln S.",
                    "initial": "L.S.",
                    "last": "Prado"
                },
                {
                    "first": "Maria Luiza L.S.",
                    "initial": "M.L.L.S.",
                    "last": "Guerra"
                },
                {
                    "first": "Glaucia Gama",
                    "initial": "G.G.",
                    "last": "RahalAires"
                },
                {
                    "first": "Orlando Cesar",
                    "initial": "O.C.",
                    "last": "Mantese"
                },
                {
                    "first": "Eitan",
                    "initial": "E.",
                    "last": "Berezin"
                },
                {
                    "first": "Cicero",
                    "initial": "C.",
                    "last": "Dias"
                },
                {
                    "first": "Cristiana",
                    "initial": "C.",
                    "last": "Nascimento"
                },
                {
                    "first": "Joice",
                    "initial": "J.",
                    "last": "Reis"
                },
                {
                    "first": "Ana Lucia",
                    "initial": "A.L.",
                    "last": "Andrade"
                },
                {
                    "first": "Solange",
                    "initial": "S.",
                    "last": "Andrade"
                },
                {
                    "first": "Flavia",
                    "initial": "F.",
                    "last": "Lobos"
                },
                {
                    "first": "Camile",
                    "initial": "C.",
                    "last": "de Moraes"
                },
                {
                    "first": "Eliane Castro",
                    "initial": "E.C.",
                    "last": "de Barros"
                },
                {
                    "first": "M\u00e1rcia Lopes",
                    "initial": "M.L.",
                    "last": "de Carvalho"
                },
                {
                    "first": "Elias Duarte Gon\u00e7alves",
                    "initial": "E.D.G.",
                    "last": "Correiavaccines"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2015.10.007",
            "firstpage": "6145",
            "issn": "0264410X",
            "lastpage": "6148",
            "pmid": "26469718",
            "pub_year": 2015,
            "title": "Indirect cohort analysis of 10-valent pneumococcal conjugate vaccine effectiveness against vaccine-type and vaccine-related invasive pneumococcal disease",
            "volume": "33"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Jukka",
                    "initial": "J.",
                    "last": "Jokinen"
                },
                {
                    "first": "Hanna",
                    "initial": "H.",
                    "last": "Rinta-Kokko"
                },
                {
                    "first": "Lotta",
                    "initial": "L.",
                    "last": "Siira"
                },
                {
                    "first": "Arto A.",
                    "initial": "A.A.",
                    "last": "Palmu"
                },
                {
                    "first": "Mikko J.",
                    "initial": "M.J.",
                    "last": "Virtanen"
                },
                {
                    "first": "Hanna",
                    "initial": "H.",
                    "last": "Nohynek"
                },
                {
                    "first": "Anni",
                    "initial": "A.",
                    "last": "Virolainen-Julkunen"
                },
                {
                    "first": "Maija",
                    "initial": "M.",
                    "last": "Toropainen"
                },
                {
                    "first": "J. Pekka",
                    "initial": "J.P.",
                    "last": "Nuorti"
                }
            ],
            "doi": "10.1371/journal.pone.0120290",
            "issn": "19326203",
            "pmid": "25781031",
            "pub_year": 2015,
            "title": "Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children - A population-based study",
            "volume": "10"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "De Wals"
                },
                {
                    "first": "Genevi\u00e8ve",
                    "initial": "G.",
                    "last": "Deceuninck"
                },
                {
                    "first": "Gaston",
                    "initial": "G.",
                    "last": "De Serres"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.06.104",
            "firstpage": "2053",
            "issn": "0264410X",
            "lastpage": "2054",
            "pmid": "27021043",
            "pub_year": 2016,
            "title": "Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada",
            "volume": "34"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Genevi\u00e8ve",
                    "initial": "G.",
                    "last": "Deceuninck"
                },
                {
                    "first": "Gaston",
                    "initial": "G.",
                    "last": "De Serres"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Boulianne"
                },
                {
                    "first": "Brigitte",
                    "initial": "B.",
                    "last": "Lefebvre"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "De Wals"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.04.005",
            "firstpage": "2684",
            "issn": "0264410X",
            "lastpage": "2689",
            "pmid": "25887086",
            "pub_year": 2015,
            "title": "Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada",
            "volume": "33"
        },
        "b0105": {
            "authors": [
                {
                    "first": "F\u00e9lix",
                    "initial": "F.",
                    "last": "Ome\u00f1aca"
                },
                {
                    "first": "Jose Manuel",
                    "initial": "J.M.",
                    "last": "Merino"
                },
                {
                    "first": "Juan Carlos",
                    "initial": "J.C.",
                    "last": "Tejedor"
                },
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Constantopoulos"
                },
                {
                    "first": "Vassiliki",
                    "initial": "V.",
                    "last": "Papaevangelou"
                },
                {
                    "first": "Dimitrios",
                    "initial": "D.",
                    "last": "Kafetzis"
                },
                {
                    "first": "Antigoni",
                    "initial": "A.",
                    "last": "Tsirka"
                },
                {
                    "first": "Fani",
                    "initial": "F.",
                    "last": "Athanassiadou"
                },
                {
                    "first": "Marina",
                    "initial": "M.",
                    "last": "Anagnostakou"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Fran\u00e7ois"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1542/peds.2010-1184",
            "firstpage": "e290",
            "issn": "00314005",
            "lastpage": "e298",
            "pmid": "21727108",
            "pub_year": 2011,
            "title": "Immunization of preterm infants with 10-valent pneumococcal conjugate vaccine",
            "volume": "128"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Shabir A.",
                    "initial": "S.A.",
                    "last": "Madhi"
                },
                {
                    "first": "Anthonet",
                    "initial": "A.",
                    "last": "Koen"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Jose"
                },
                {
                    "first": "Nadia",
                    "initial": "N.",
                    "last": "Van Niekerk"
                },
                {
                    "first": "Peter V.",
                    "initial": "P.V.",
                    "last": "Adrian"
                },
                {
                    "first": "Clare",
                    "initial": "C.",
                    "last": "Cutland"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Fran\u00e7ois"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Ruiz-Gui\u00f1az\u00fa"
                },
                {
                    "first": "Juan Pablo",
                    "initial": "J.P.",
                    "last": "Yarzabal"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Moreira"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1097/MD.0000000000005881",
            "issn": "00257974",
            "pmid": "28079828",
            "pub_year": 2017,
            "title": "Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status",
            "volume": "96"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Sodiomon B.",
                    "initial": "S.B.",
                    "last": "Sirima"
                },
                {
                    "first": "Alfred",
                    "initial": "A.",
                    "last": "Tiono"
                },
                {
                    "first": "Zakaria",
                    "initial": "Z.",
                    "last": "Gansan\u00e9"
                },
                {
                    "first": "Mohamadou",
                    "initial": "M.",
                    "last": "Siribi\u00e9"
                },
                {
                    "first": "Ang\u00e8le",
                    "initial": "A.",
                    "last": "Zongo"
                },
                {
                    "first": "Alphonse",
                    "initial": "A.",
                    "last": "Ou\u00e9draogo"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Fran\u00e7ois"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Strezova"
                },
                {
                    "first": "Kurt",
                    "initial": "K.",
                    "last": "Dobbelaere"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                }
            ],
            "doi": "10.1097/INF.0000000000001518",
            "firstpage": "e136",
            "issn": "08913668",
            "lastpage": "e150",
            "pmid": "28403055",
            "pub_year": 2016,
            "title": "Immunogenicity and safety of 10-valent pneumococcal nontypeable haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered to children with sickle cell disease between 8 weeks and 2 years of age: A phase III, open, controlled study",
            "volume": "36"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Henckaerts"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "Lindsey",
                    "initial": "L.",
                    "last": "Ashton"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Poolman"
                }
            ],
            "doi": "10.1128/CVI.13.3.356-360.2006",
            "firstpage": "356",
            "issn": "15566811",
            "lastpage": "360",
            "pmid": "16522777",
            "pub_year": 2006,
            "title": "Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera",
            "volume": "13"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Jan T.",
                    "initial": "J.T.",
                    "last": "Poolman"
                },
                {
                    "first": "Carl E.",
                    "initial": "C.E.",
                    "last": "Frasch"
                },
                {
                    "first": "Helena",
                    "initial": "H.",
                    "last": "K\u00e4yhty"
                },
                {
                    "first": "Pascal",
                    "initial": "P.",
                    "last": "Lestrate"
                },
                {
                    "first": "Shabir A.",
                    "initial": "S.A.",
                    "last": "Madhi"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Henckaerts"
                }
            ],
            "doi": "10.1128/CVI.00289-09",
            "firstpage": "134",
            "issn": "15566811",
            "lastpage": "142",
            "pmid": "19889940",
            "pub_year": 2010,
            "title": "Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines",
            "volume": "17"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Moon H.",
                    "initial": "M.H.",
                    "last": "Nahm"
                },
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Briles"
                },
                {
                    "first": "Xinhong",
                    "initial": "X.",
                    "last": "Yu"
                }
            ],
            "doi": "10.1016/S0264-410X(00)00044-X",
            "firstpage": "2768",
            "issn": "0264410X",
            "lastpage": "2771",
            "pmid": "10781864",
            "pub_year": 2000,
            "title": "Development of a multi-specificity opsonophagocytic killing assay",
            "volume": "18"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Thomas V.",
                    "initial": "T.V.",
                    "last": "Adamkiewicz"
                },
                {
                    "first": "Benjamin J.",
                    "initial": "B.J.",
                    "last": "Silk"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Howgate"
                },
                {
                    "first": "Wendy",
                    "initial": "W.",
                    "last": "Baughman"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Strayhorn"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Sullivan"
                },
                {
                    "first": "Monica M.",
                    "initial": "M.M.",
                    "last": "Farley"
                }
            ],
            "doi": "10.1542/peds.2007-0018",
            "firstpage": "562",
            "issn": "00314005",
            "lastpage": "569",
            "pmid": "18310206",
            "pub_year": 2008,
            "title": "Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life",
            "volume": "121"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Natasha B.",
                    "initial": "N.B.",
                    "last": "Halasa"
                },
                {
                    "first": "Sadhna M.",
                    "initial": "S.M.",
                    "last": "Shankar"
                },
                {
                    "first": "Thomas R.",
                    "initial": "T.R.",
                    "last": "Talbot"
                },
                {
                    "first": "Patrick G.",
                    "initial": "P.G.",
                    "last": "Arbogast"
                },
                {
                    "first": "Ed F.",
                    "initial": "E.F.",
                    "last": "Mitchel"
                },
                {
                    "first": "Winfred C.",
                    "initial": "W.C.",
                    "last": "Wang"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Schaffner"
                },
                {
                    "first": "Allen S.",
                    "initial": "A.S.",
                    "last": "Craig"
                },
                {
                    "first": "Marie R.",
                    "initial": "M.R.",
                    "last": "Griffin"
                }
            ],
            "doi": "10.1086/516781",
            "firstpage": "1428",
            "issn": "10584838",
            "lastpage": "1433",
            "pmid": "17479937",
            "pub_year": 2007,
            "title": "Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine",
            "volume": "44"
        }
    },
    "body_text": [
        {
            "endOffset": 30935,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0040",
            "sentence": "All solicited local reactions were considered causally related to vaccinations.",
            "startOffset": 30856,
            "title": "Reactogenicity and safety assessment"
        },
        {
            "endOffset": 34670,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "For serotype 19A, 94.4% and 95.2% of participants had antibody concentrations \u22650.2 \u00b5g/mL in the at-risk primed and at-risk unprimed group, respectively (Table 2).",
            "startOffset": 34508,
            "title": "Immunogenicity results"
        },
        {
            "endOffset": 27364,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "The treatment numbers were allocated at the investigator site by a central randomization system to control the number of children enrolled in each age strata and group, and to limit the allowed number of children with SCD.",
            "startOffset": 27142,
            "title": "Study design and population"
        },
        {
            "endOffset": 32880,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "Reactogenicity analyses were performed on the 2\u20134 years and 5\u201317 years age categories, and unsolicited AEs and SAEs on the 2\u201317 years and 2\u20134 years age categories.",
            "startOffset": 32717,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 27712,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "The study protocol was approved by local ethics committees and regulatory authorities.",
            "startOffset": 27626,
            "title": "Study design and population"
        },
        {
            "endOffset": 34507,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "One month after completion of study vaccination, all participants in the at-risk population had antibody concentrations \u22650.2 \u00b5g/mL for vaccine pneumococcal serotypes and serotype 6A.",
            "startOffset": 34325,
            "title": "Immunogenicity results"
        },
        {
            "endOffset": 39268,
            "parents": [],
            "secId": "s0080",
            "sentence": "Even though these medical conditions may alter immune system function, children in this study were able to develop robust immune responses after PHiD-CV vaccination.",
            "startOffset": 39103,
            "title": "Discussion"
        },
        {
            "endOffset": 39102,
            "parents": [],
            "secId": "s0080",
            "sentence": "To our knowledge, no previous study has investigated the immunogenicity or safety of PHiD-CV in unprimed or primed children with asplenia or splenic dysfunction.",
            "startOffset": 38941,
            "title": "Discussion"
        },
        {
            "endOffset": 31551,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "A total of 60 participants were planned for enrolment in the 2\u20134 years age category, in order to have around 25 evaluable participants in each at-risk and control groups in the according-to-protocol (ATP) cohort for immunogenicity with drop-out and elimination rate of around 17%.",
            "startOffset": 31271,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 27836,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "Informed consent was obtained from the parents or legally acceptable representatives (LARs) of each child before enrolment.",
            "startOffset": 27713,
            "title": "Study design and population"
        },
        {
            "endOffset": 32417,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "If antibody concentrations and OPA titers were below the assay cut-offs, an arbitrary value of half of the cut-off was taken for GMC and GMT calculations.",
            "startOffset": 32263,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 41249,
            "parents": [],
            "secId": "s0080",
            "sentence": "Disease conditions linked with splenic dysfunction are often less frequently diagnosed in the younger age groups compared to older age groups.",
            "startOffset": 41107,
            "title": "Discussion"
        },
        {
            "endOffset": 42482,
            "parents": [],
            "secId": "s0085",
            "sentence": "In this descriptive study, PHiD-CV was immunogenic in at-risk children between 2\u201317 years of age with asplenia or splenic dysfunction when administered either as a 2-dose catch-up vaccination in unprimed children or as a single dose in primed children.",
            "startOffset": 42230,
            "title": "Conclusion"
        },
        {
            "endOffset": 30742,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0040",
            "sentence": "AE intensity was graded on a scale from 1 (mild) to 3 (severe).",
            "startOffset": 30679,
            "title": "Reactogenicity and safety assessment"
        },
        {
            "endOffset": 35222,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "In both at-risk groups, increases in OPA GMTs were observed from pre-vaccination to one month after completion of study vaccination for most serotypes (all except for serotypes 6B, 14 and 23F in the at-risk primed group) (Table 3).",
            "startOffset": 34991,
            "title": "Immunogenicity results"
        },
        {
            "endOffset": 23536,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "b0005": {
                    "endOffset": 23535,
                    "startOffset": 23532
                }
            },
            "secId": "s0010",
            "sentence": "Individuals with asplenia (anatomical or functional) or splenic dysfunction (e.g., sickle cell disease [SCD]), or with complement deficiencies are at increased risk of infection caused by encapsulated bacteria such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b [1].",
            "startOffset": 23230,
            "title": "Background"
        },
        {
            "endOffset": 30110,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0035",
            "sentence": "Antibodies against the protein D carrier were measured using an enzyme-linked immunosorbent assay (ELISA) developed by GSK (at GSK laboratories, Rixensart, Belgium).",
            "startOffset": 29945,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 32958,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "The statistical analyses were performed using the Statistical Analysis System.",
            "startOffset": 32880,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 33801,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "One child had SCD.",
            "startOffset": 33783,
            "title": "Study population"
        },
        {
            "endOffset": 35572,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Increases in protein D antibody GMCs were observed from pre-vaccination to one month after completion of study vaccination (Table 4).",
            "startOffset": 35439,
            "title": "Immunogenicity results"
        },
        {
            "endOffset": 38348,
            "parents": [],
            "secId": "s0080",
            "sentence": "OPA GMTs increased from pre- to one month after the last vaccination for each vaccine and vaccine related serotype in at-risk unprimed children and for most serotypes in primed children (except for serotypes 6B, 14 and 23F that tended to be lower post-vaccination).",
            "startOffset": 38083,
            "title": "Discussion"
        },
        {
            "endOffset": 31004,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0040",
            "sentence": "The causality of all the other AEs was assessed by the investigator.",
            "startOffset": 30936,
            "title": "Reactogenicity and safety assessment"
        },
        {
            "endOffset": 31942,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "Immunogenicity analyses were performed on the ATP cohort for immunogenicity (2\u201317 years at-risk population and 2\u20134 years control population) that included all eligible children who complied with protocol-defined study procedures and intervals defined in the protocol, with no elimination criteria during the study, and who had results available for at least one vaccine antigen or protein D.",
            "startOffset": 31551,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 26895,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "Eligible study participants in the at-risk groups were children with asplenia, splenic dysfunction or complement deficiencies (Table S1).",
            "startOffset": 26758,
            "title": "Study design and population"
        },
        {
            "endOffset": 27473,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "The treatment numbers were allocated by dose (1 dose for primed children and 2 doses for unprimed children).",
            "startOffset": 27365,
            "title": "Study design and population"
        },
        {
            "endOffset": 39716,
            "parents": [],
            "secId": "s0080",
            "sentence": "Given the low number of participants, the study outcomes need to be interpreted with caution.",
            "startOffset": 39623,
            "title": "Discussion"
        },
        {
            "endOffset": 37804,
            "parents": [],
            "secId": "s0080",
            "sentence": "In this study, PHiD-CV was immunogenic in at-risk children with splenic dysfunctions, including asplenia, aged between 2 and 17 years when administered either as a 2-dose catch-up vaccination in unprimed children or as a single dose in primed children.",
            "startOffset": 37552,
            "title": "Discussion"
        },
        {
            "endOffset": 42219,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 42058,
                    "startOffset": 42051
                },
                "b0075": {
                    "endOffset": 42058,
                    "startOffset": 42051
                },
                "b0080": {
                    "endOffset": 42058,
                    "startOffset": 42051
                },
                "b0085": {
                    "endOffset": 42058,
                    "startOffset": 42051
                },
                "b0090": {
                    "endOffset": 42058,
                    "startOffset": 42051
                },
                "b0095": {
                    "endOffset": 42058,
                    "startOffset": 42051
                },
                "b0100": {
                    "endOffset": 42058,
                    "startOffset": 42051
                }
            },
            "secId": "s0080",
            "sentence": "As PHiD-CV efficacy and effectiveness/impact was demonstrated in large double-blind, randomized, controlled trials and post-marketing studies [14\u201320] and it continues to be included in NIPs in many countries, more data are being generated, including data on the impact of this vaccine in high-risk populations.",
            "startOffset": 41909,
            "title": "Discussion"
        },
        {
            "endOffset": 26758,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "Detailed inclusion and exclusion criteria are described in supplementary text S1.",
            "startOffset": 26677,
            "title": "Study design and population"
        },
        {
            "endOffset": 39513,
            "parents": [],
            "secId": "s0080",
            "sentence": "This study provides important results on the use of PHiD-CV in this at-risk population of children highly susceptible to pneumococcal infections.",
            "startOffset": 39368,
            "title": "Discussion"
        },
        {
            "endOffset": 24143,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "b0025": {
                    "endOffset": 24069,
                    "startOffset": 24066
                },
                "b0030": {
                    "endOffset": 24142,
                    "startOffset": 24137
                },
                "b0035": {
                    "endOffset": 24142,
                    "startOffset": 24137
                }
            },
            "secId": "s0010",
            "sentence": "The use of the 23-valent pneumococcal plain polysaccharide vaccine (PPSV23) has been recommended for many years in asplenic or immunocompromised children aged \u22652 years [5], but not in younger children, for whom this vaccine is ineffective [6,7].",
            "startOffset": 23898,
            "title": "Background"
        },
        {
            "endOffset": 28304,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0025",
            "sentence": "In both at-risk and control groups, unprimed children received a 2-dose catch-up vaccination with PHiD-CV (Synflorix, GSK), with an interval of at least 2 months between doses, and primed children received 1 dose of PHiD-CV (Fig. S1).",
            "startOffset": 28070,
            "title": "Vaccination schedule and vaccines"
        },
        {
            "endOffset": 32601,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "The percentages of subjects with solicited or unsolicited AEs were tabulated with exact 95% CIs.",
            "startOffset": 32505,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 37321,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Reactogenicity and safety results"
                }
            ],
            "secId": "s0075",
            "sentence": "One grade 3 unsolicited AE was assessed by the investigator as vaccination-related (somnolence in the at-risk unprimed group).",
            "startOffset": 37195,
            "title": "Unsolicited and serious adverse events"
        },
        {
            "endOffset": 25986,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "This phase III, open-label, controlled, multi-center study (ClinicalTrials.gov: NCT01746108) was conducted between June 2013 and June 2015 in Poland and the Russian Federation in 3 centers in each country.",
            "startOffset": 25781,
            "title": "Study design and population"
        },
        {
            "endOffset": 29864,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0035",
            "sentence": "Opsonophagocytic activity (OPA) against each vaccine pneumococcal serotype and vaccine-related serotypes 6A and 19A was measured by a validated multiplex OPA assay (at University College of London, Institute of Child Health, London, United Kingdom).",
            "startOffset": 29615,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 32124,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "The percentages of children reaching assay cut-offs, antibody geometric mean concentrations (GMCs) and OPA geometric mean titers (GMTs) were calculated with 95% confidence intervals.",
            "startOffset": 31942,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 35438,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "For protein D, one month after completion of study vaccination, 50.0% and 84.2% of children in the at-risk primed and unprimed groups, respectively, had anti-protein D antibody concentrations \u2265153 EL.U/mL (Table 4).",
            "startOffset": 35223,
            "title": "Immunogenicity results"
        },
        {
            "endOffset": 37194,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Reactogenicity and safety results"
                }
            ],
            "secId": "s0075",
            "sentence": "The most common unsolicited AE was rhinitis reported after 4 out of 54 doses (7.4%) in the at-risk unprimed group.",
            "startOffset": 37080,
            "title": "Unsolicited and serious adverse events"
        },
        {
            "endOffset": 34990,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "For each vaccine and vaccine-related pneumococcal serotype, all children had OPA titers \u22658, except for serotype 1 (42.9% and 66.7% in the at-risk primed and unprimed groups, respectively), and serotypes 5, 23F and 19A (93.3% each in the at-risk primed group) at one month after completion of study vaccination (Table 3).",
            "startOffset": 34670,
            "title": "Immunogenicity results"
        },
        {
            "endOffset": 37897,
            "parents": [],
            "secId": "s0080",
            "sentence": "PHiD-CV was generally well tolerated in at-risk children and no safety concerns were raised.",
            "startOffset": 37805,
            "title": "Discussion"
        },
        {
            "endOffset": 29441,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 29440,
                    "startOffset": 29436
                }
            },
            "secId": "s0035",
            "sentence": "Immunoglobulin G (IgG) antibodies against vaccine pneumococcal serotypes and vaccine-related serotypes (6A and 19A) were measured by enzyme-linked immunosorbent assay with serotype 22F polysaccharide adsorption (22F-ELISA) (at N\u00e9omed-Labs Inc, Quebec, Canada), as described previously [24].",
            "startOffset": 29151,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 31065,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "All study objectives were descriptive.",
            "startOffset": 31027,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 37080,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Reactogenicity and safety results"
                }
            ],
            "secId": "s0075",
            "sentence": "During the 31-day post-vaccination period, at least 1 unsolicited AE was reported after 2 out of 18 doses (11.1%), 14 out of 54 doses (25.9%) and 4 out of 12 doses (33.3%) in the 2\u201317 years at-risk primed, at-risk unprimed and 2\u20134 years control unprimed groups, respectively.",
            "startOffset": 36805,
            "title": "Unsolicited and serious adverse events"
        },
        {
            "endOffset": 32716,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "SAE occurrence was described.",
            "startOffset": 32687,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 40422,
            "parents": [],
            "secId": "s0080",
            "sentence": "Moreover, a descriptive comparison between the 2\u20134-year-old at-risk children and the age-matched healthy control children could not be done because we did not succeed to enroll the planned number of children in the youngest age group due to recruitment difficulties.",
            "startOffset": 40156,
            "title": "Discussion"
        },
        {
            "endOffset": 23898,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "b0020": {
                    "endOffset": 23897,
                    "startOffset": 23894
                }
            },
            "secId": "s0010",
            "sentence": "Immunization is an important strategy for preventing infections in this high-risk group [4].",
            "startOffset": 23806,
            "title": "Background"
        },
        {
            "endOffset": 28367,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0025",
            "sentence": "Vaccine composition is described in the supplementary text S2.",
            "startOffset": 28305,
            "title": "Vaccination schedule and vaccines"
        },
        {
            "endOffset": 29006,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0030",
            "sentence": "The secondary objectives were to assess PHiD-CV immunogenicity when administered to healthy primed or unprimed children aged 2\u20134 years, and its reactogenicity and safety in children aged 2\u201317 years in both at-risk and control groups, regardless of the priming status.",
            "startOffset": 28739,
            "title": "Objectives"
        },
        {
            "endOffset": 25604,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 25492,
                    "startOffset": 25488
                },
                "b0110": {
                    "endOffset": 25563,
                    "startOffset": 25559
                },
                "b0115": {
                    "endOffset": 25603,
                    "startOffset": 25599
                }
            },
            "secId": "s0010",
            "sentence": "Previous clinical studies assessed PHiD-CV use in high-risk children, such as premature infants [21], infants infected with or exposed to human immunodeficiency virus [22], and infants and toddlers with SCD [23].",
            "startOffset": 25392,
            "title": "Background"
        },
        {
            "endOffset": 23701,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "b0010": {
                    "endOffset": 23700,
                    "startOffset": 23697
                }
            },
            "secId": "s0010",
            "sentence": "The risk of life-threatening infections is particularly high in young children with asplenia or splenic dysfunction, as compared with older children and adults [2].",
            "startOffset": 23537,
            "title": "Background"
        },
        {
            "endOffset": 41106,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 41105,
                    "startOffset": 41101
                }
            },
            "secId": "s0080",
            "sentence": "A recent monocenter PHiD-CV study in Burkina Faso recruited 150 infants and toddlers with SCD aged 2\u201324 months [23].",
            "startOffset": 40990,
            "title": "Discussion"
        },
        {
            "endOffset": 31270,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "A total of 100 participants were planned to be enrolled: 70 in the at-risk groups (30 in the 2\u20134 years, 20 in the 5\u201310 years, and 20 in the 11\u201317 years age strata) and 30 in the control group (2\u20134 years).",
            "startOffset": 31066,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 36000,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Reactogenicity and safety results"
                }
            ],
            "secId": "s0070",
            "sentence": "The most frequently reported solicited injection site AEs in 2\u20134-year-olds were pain in the at-risk unprimed group and redness in the control unprimed group (Table 5A).",
            "startOffset": 35832,
            "title": "Solicited adverse events"
        },
        {
            "endOffset": 26677,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "For the 2\u20134 years at-risk group, healthy age-matched children were enrolled as control group.",
            "startOffset": 26584,
            "title": "Study design and population"
        },
        {
            "endOffset": 38682,
            "parents": [],
            "secId": "s0080",
            "sentence": "These data suggest that previous vaccination status may have an impact on PCV immunogenicity.",
            "startOffset": 38589,
            "title": "Discussion"
        },
        {
            "endOffset": 33989,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The demographic characteristics of the children in the TVC are summarized in Table 1.",
            "startOffset": 33904,
            "title": "Study population"
        },
        {
            "endOffset": 41908,
            "parents": [],
            "refoffsets": {
                "b0135": {
                    "endOffset": 41863,
                    "startOffset": 41859
                },
                "b0140": {
                    "endOffset": 41906,
                    "startOffset": 41902
                }
            },
            "secId": "s0080",
            "sentence": "Although this study had immunogenicity and safety objectives only and therefore could not evaluate clinical vaccine efficacy, previous observations have demonstrated that vaccine immunogenicity of PCV translated to vaccine efficiency in an at-risk population: after the introduction of PCV7, a significant reduction of invasive pneumococcal disease was observed in children with SCD (68% in children \u226410 years of age [27] and 93.4% in children \u22645 years of age [28]).",
            "startOffset": 41442,
            "title": "Discussion"
        },
        {
            "endOffset": 40155,
            "parents": [],
            "secId": "s0080",
            "sentence": "While a total of 18 primed and 28 unprimed at-risk children aged 2\u201317 years were enrolled, the number of children in each age category was very small, thus precluding any descriptive comparison between primed and unprimed at-risk children.",
            "startOffset": 39916,
            "title": "Discussion"
        },
        {
            "endOffset": 40603,
            "parents": [],
            "secId": "s0080",
            "sentence": "Other clinical studies conducted in children with asplenia or splenic dysfunction, including SCD, also report data generated in small cohorts with a low number of younger children.",
            "startOffset": 40423,
            "title": "Discussion"
        },
        {
            "endOffset": 28739,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0030",
            "sentence": "The primary objective was to assess the immunogenicity of PHiD-CV when administered to at-risk children aged 2\u201317 years, either as a 2-dose catch-up vaccination in unprimed children, or as a single dose in primed children.",
            "startOffset": 28517,
            "title": "Objectives"
        },
        {
            "endOffset": 30559,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0040",
            "sentence": "Solicited adverse events (AEs) at injection site (pain, redness and swelling for all age categories) and general AEs (drowsiness, fever, irritability and loss of appetite in the 2\u20134 years age category, and fatigue, fever, gastrointestinal symptoms and headache in the 5\u201317 years age category) were reported on diary cards within 4 days after vaccination.",
            "startOffset": 30205,
            "title": "Reactogenicity and safety assessment"
        },
        {
            "endOffset": 38941,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 38940,
                    "startOffset": 38936
                }
            },
            "secId": "s0080",
            "sentence": "A similar observation was reported in children 6\u201317 years of age with SCD vaccinated with PCV13 [12].",
            "startOffset": 38840,
            "title": "Discussion"
        },
        {
            "endOffset": 27625,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "The study was conducted in accordance with the principles of Good Clinical Practice, Declaration of Helsinki and all applicable regulatory requirements.",
            "startOffset": 27473,
            "title": "Study design and population"
        },
        {
            "endOffset": 36158,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Reactogenicity and safety results"
                }
            ],
            "secId": "s0070",
            "sentence": "The only participant in the at-risk primed group aged 2\u20134 years had pain, redness and swelling at the injection site after PHiD-CV administration (Table 5A).",
            "startOffset": 36001,
            "title": "Solicited adverse events"
        },
        {
            "endOffset": 27141,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "The list of treatment numbers was generated at GSK, using SAS (Statistical Analysis System) software.",
            "startOffset": 27040,
            "title": "Study design and population"
        },
        {
            "endOffset": 24647,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "b0025": {
                    "endOffset": 24646,
                    "startOffset": 24643
                }
            },
            "secId": "s0010",
            "sentence": "The use of PPSV23 in addition to PCVs is still recommended in children \u22652 years to protect this high-risk group against pneumococcal infection due to serotypes not included in PCVs [5].",
            "startOffset": 24462,
            "title": "Background"
        },
        {
            "endOffset": 36264,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Reactogenicity and safety results"
                }
            ],
            "secId": "s0070",
            "sentence": "In children aged 5\u201317 years, pain was the most frequently reported solicited injection site AE (Table 5A).",
            "startOffset": 36158,
            "title": "Solicited adverse events"
        },
        {
            "endOffset": 36371,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Reactogenicity and safety results"
                }
            ],
            "secId": "s0070",
            "sentence": "Loss of appetite was the most commonly reported solicited general AE in children aged 2\u20134 years (Table 5B).",
            "startOffset": 36264,
            "title": "Solicited adverse events"
        },
        {
            "endOffset": 25739,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "Here, we studied the safety and immunogenicity of PHiD-CV in high-risk children 2\u201317 years of age with asplenia or splenic dysfunction.",
            "startOffset": 25604,
            "title": "Background"
        },
        {
            "endOffset": 38588,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 38587,
                    "startOffset": 38583
                }
            },
            "secId": "s0080",
            "sentence": "In another study, antibody GMCs did not increase for several serotypes (1, 3, 4, 5, 7F, 9V, 14, 18C and 19A) following administration of subsequent PCV13 doses in children with SCD who previously had received one or more PPSV23 doses [12].",
            "startOffset": 38349,
            "title": "Discussion"
        },
        {
            "endOffset": 36762,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Reactogenicity and safety results"
                }
            ],
            "secId": "s0070",
            "sentence": "No grade 3 solicited general AEs and no large swelling reactions were reported.",
            "startOffset": 36683,
            "title": "Solicited adverse events"
        },
        {
            "endOffset": 36683,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Reactogenicity and safety results"
                }
            ],
            "secId": "s0070",
            "sentence": "Regardless of age category, most of the solicited general AEs were assessed by the investigators as related to vaccination.",
            "startOffset": 36560,
            "title": "Solicited adverse events"
        },
        {
            "endOffset": 29615,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 29614,
                    "startOffset": 29610
                }
            },
            "secId": "s0035",
            "sentence": "The 0.2 \u00b5g/mL threshold is equivalent to antibody concentrations \u22650.35 \u00b5g/mL measured by the non-22F-ELISA of the reference laboratory of the World Health Organization [25].",
            "startOffset": 29442,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 39915,
            "parents": [],
            "secId": "s0080",
            "sentence": "Unlike most PCV studies, both primed and unprimed at-risk children were eligible for inclusion in this study, which could have offered the opportunity to descriptively compare the concurrent groups.",
            "startOffset": 39717,
            "title": "Discussion"
        },
        {
            "endOffset": 33479,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "In the TVC, out of 46 at-risk children, 34 (73.9%) had asplenia, 11 (23.9%) had splenic dysfunction and 1 (2.2%) had complement deficiencies.",
            "startOffset": 33338,
            "title": "Study population"
        },
        {
            "endOffset": 24461,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "b0025": {
                    "endOffset": 24460,
                    "startOffset": 24457
                }
            },
            "secId": "s0010",
            "sentence": "Many countries have now implemented routine pediatric vaccination with PCVs in their national immunization program (NIP), and also recommend PCVs for children at high risk for pneumococcal disease [5].",
            "startOffset": 24260,
            "title": "Background"
        },
        {
            "endOffset": 34324,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Increases in antibody GMCs were observed from pre-vaccination to one month post-dose 1 in at-risk primed children and post-dose 2 in at-risk unprimed children for vaccine pneumococcal serotypes and vaccine-related serotypes 6A and 19A (Table 2).",
            "startOffset": 34079,
            "title": "Immunogenicity results"
        },
        {
            "endOffset": 24864,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "b0040": {
                    "endOffset": 24787,
                    "startOffset": 24781
                },
                "b0045": {
                    "endOffset": 24787,
                    "startOffset": 24781
                },
                "b0050": {
                    "endOffset": 24787,
                    "startOffset": 24781
                },
                "b0055": {
                    "endOffset": 24787,
                    "startOffset": 24781
                },
                "b0060": {
                    "endOffset": 24787,
                    "startOffset": 24781
                }
            },
            "secId": "s0010",
            "sentence": "A number of clinical studies have been conducted with PCV13 and its predecessor PCV7 in children with asplenia or splenic dysfunction [8\u201312], suggesting that these vaccines were immunogenic in this at-risk population.",
            "startOffset": 24647,
            "title": "Background"
        },
        {
            "endOffset": 32262,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "Antibody GMCs and OPA GMTs were calculated by taking the anti-log of the mean of the log antibody concentration or titer transformations.",
            "startOffset": 32125,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 33337,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The recruitment encountered difficulties, especially for the 2\u20134-year-old children, resulting in lower numbers of at-risk participants and no participants in the control primed group.",
            "startOffset": 33154,
            "title": "Study population"
        },
        {
            "endOffset": 33153,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Among 52 children enrolled and included in the TVC, 48 completed the study, and 45 were included in the ATP cohort for immunogenicity (details are presented in Fig. 1).",
            "startOffset": 32985,
            "title": "Study population"
        },
        {
            "endOffset": 39367,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 39366,
                    "startOffset": 39362
                }
            },
            "secId": "s0080",
            "sentence": "This is in line with previous findings showing immunogenicity of PHiD-CV in infants with SCD [23].",
            "startOffset": 39269,
            "title": "Discussion"
        },
        {
            "endOffset": 30166,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0035",
            "sentence": "The cut-off of the assay was 153 ELISA units (EL.U)/mL.",
            "startOffset": 30111,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 34054,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "All enrolled children were of White-Caucasian/European heritage.",
            "startOffset": 33990,
            "title": "Study population"
        },
        {
            "endOffset": 28034,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "A protocol summary is available at www.gsk-clinicalstudyregister.com (study ID: 115884).",
            "startOffset": 27946,
            "title": "Study design and population"
        },
        {
            "endOffset": 37541,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Reactogenicity and safety results"
                }
            ],
            "secId": "s0075",
            "sentence": "Throughout the study, 1 non-fatal SAE (respiratory tract infection) was reported for a child in the at-risk unprimed group (2\u20134 years age strata), and it was considered by the investigators as not related to vaccination.",
            "startOffset": 37321,
            "title": "Unsolicited and serious adverse events"
        },
        {
            "endOffset": 30856,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0040",
            "sentence": "Grade 3 intensity scale definition for solicited AEs and definition of SAE are included in supplementary text S3.",
            "startOffset": 30743,
            "title": "Reactogenicity and safety assessment"
        },
        {
            "endOffset": 41442,
            "parents": [],
            "secId": "s0080",
            "sentence": "Furthermore, as these children are at increased risk for infections, they are likely to be vaccinated as soon as possible after diagnosis and thus are difficult to recruit in a clinical study.",
            "startOffset": 41250,
            "title": "Discussion"
        },
        {
            "endOffset": 32686,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "Similar calculations were performed for grade 3 AEs and for vaccination-related AEs.",
            "startOffset": 32602,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 40989,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 40906,
                    "startOffset": 40903
                },
                "b0045": {
                    "endOffset": 40988,
                    "startOffset": 40985
                },
                "b0055": {
                    "endOffset": 40775,
                    "startOffset": 40771
                }
            },
            "secId": "s0080",
            "sentence": "This is the case for several PCV7 studies, of which one in Poland enrolled 30 asplenic children between 4.5 months and 19.5 years old, with a mean age of 12 years old [11], while another study in the United States enrolled 35 infants with SCD aged under 2 months and 13 aged between 2 and 12 months [8], and a multicenter study in France enrolled 51 infants with SCD aged 2 months [9].",
            "startOffset": 40604,
            "title": "Discussion"
        },
        {
            "endOffset": 39622,
            "parents": [],
            "secId": "s0080",
            "sentence": "Limitations of this study included a descriptive design, which did not allow drawing statistical conclusions.",
            "startOffset": 39513,
            "title": "Discussion"
        },
        {
            "endOffset": 25292,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "b0065": {
                    "endOffset": 25033,
                    "startOffset": 25029
                },
                "b0070": {
                    "endOffset": 25195,
                    "startOffset": 25191
                },
                "b0075": {
                    "endOffset": 25212,
                    "startOffset": 25208
                },
                "b0080": {
                    "endOffset": 25258,
                    "startOffset": 25251
                },
                "b0085": {
                    "endOffset": 25258,
                    "startOffset": 25251
                },
                "b0090": {
                    "endOffset": 25272,
                    "startOffset": 25268
                },
                "b0095": {
                    "endOffset": 25291,
                    "startOffset": 25284
                },
                "b0100": {
                    "endOffset": 25291,
                    "startOffset": 25284
                }
            },
            "secId": "s0010",
            "sentence": "Safety and immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV, GSK) in young children has been demonstrated [13] as well as its efficacy and effectiveness/impact against invasive pneumococcal disease in large double-blind, randomized, controlled trials in Latin America [14] and Finland [15], and post-marketing studies in Brazil [16,17], Finland [18] and Quebec [19,20].",
            "startOffset": 24864,
            "title": "Background"
        },
        {
            "endOffset": 33904,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Details regarding participants\u2019 medical history and other underlying conditions are shown in Table S2.",
            "startOffset": 33802,
            "title": "Study population"
        },
        {
            "endOffset": 28504,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0025",
            "sentence": "The vaccine was administered as intramuscular injection into the deltoid (non-dominant side) or thigh (if deltoid size was not adequate).",
            "startOffset": 28367,
            "title": "Vaccination schedule and vaccines"
        },
        {
            "endOffset": 27039,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "Inclusion of the participants in each age strata (or to study group for 2\u20134-year-old children) was performed based on age and medical condition.",
            "startOffset": 26895,
            "title": "Study design and population"
        },
        {
            "endOffset": 26583,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "At-risk children aged 2\u201317 years were divided into 2\u20134 (24\u201359 months), 5\u201310 and 11\u201317 years age strata.",
            "startOffset": 26480,
            "title": "Study design and population"
        },
        {
            "endOffset": 27945,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "In addition, written informed assent was obtained from each study participant at or above the age of assent.",
            "startOffset": 27837,
            "title": "Study design and population"
        },
        {
            "endOffset": 29151,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0035",
            "sentence": "Blood samples were collected before dose 1 and 1 month after each dose, regardless of vaccination schedule (Fig. S1).",
            "startOffset": 29034,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 23805,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "b0015": {
                    "endOffset": 23804,
                    "startOffset": 23801
                }
            },
            "secId": "s0010",
            "sentence": "Antibiotic prophylaxis is recommended, but not always efficient due to antibiotic-resistant strains [3].",
            "startOffset": 23701,
            "title": "Background"
        },
        {
            "endOffset": 30679,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0040",
            "sentence": "Unsolicited AEs were reported within 31 days after vaccination, and serious adverse events (SAEs) throughout the study.",
            "startOffset": 30560,
            "title": "Reactogenicity and safety assessment"
        },
        {
            "endOffset": 32504,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0045",
            "sentence": "Reactogenicity and safety analyses were performed on the total vaccinated cohort (TVC).",
            "startOffset": 32417,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 24259,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "With the advent of pneumococcal conjugate vaccines (PCVs), protection of younger children <2 years became possible.",
            "startOffset": 24144,
            "title": "Background"
        },
        {
            "endOffset": 33599,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Of 34 children with asplenia, 17 had total splenectomy, 15 had functional asplenia and 2 had other asplenic conditions.",
            "startOffset": 33480,
            "title": "Study population"
        },
        {
            "endOffset": 35767,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Data for the control group in the 2\u20134 years of age category, are presented in Supplementary text S4 and Tables S3\u2013S5 together with the corresponding at-risk group for which they were age-matched.",
            "startOffset": 35572,
            "title": "Immunogenicity results"
        },
        {
            "endOffset": 38839,
            "parents": [],
            "secId": "s0080",
            "sentence": "The frequency of injection site pain in 5\u201317-year-old children was high: after 82.4% of doses in the at-risk primed and 82.6% of doses in the unprimed group.",
            "startOffset": 38682,
            "title": "Discussion"
        },
        {
            "endOffset": 38082,
            "parents": [],
            "secId": "s0080",
            "sentence": "In at-risk primed and unprimed children, antibody GMCs increased from pre-vaccination to one month after the last vaccination for each vaccine and vaccine-related pneumococcal serotype.",
            "startOffset": 37897,
            "title": "Discussion"
        },
        {
            "endOffset": 42518,
            "parents": [],
            "secId": "s0085",
            "sentence": "No safety concerns were identified.",
            "startOffset": 42483,
            "title": "Conclusion"
        },
        {
            "endOffset": 36560,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Reactogenicity and safety results"
                }
            ],
            "secId": "s0070",
            "sentence": "The most commonly reported solicited general AEs in the 5\u201317 years age category were fatigue and headache in the at-risk primed group and headache in the at-risk unprimed group (Table 5B).",
            "startOffset": 36372,
            "title": "Solicited adverse events"
        },
        {
            "endOffset": 29945,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 29944,
                    "startOffset": 29940
                }
            },
            "secId": "s0035",
            "sentence": "The cut-off of the assay was an opsonic titer of 8 as previously described [26].",
            "startOffset": 29865,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 33782,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The major underlying medical conditions were: hematological disorders other than SCD (17 children), chronic gastrointestinal disorders (8 children), liver disease (5) and trauma (4).",
            "startOffset": 33600,
            "title": "Study population"
        },
        {
            "endOffset": 26479,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methodology"
                }
            ],
            "secId": "s0020",
            "sentence": "Study participants were planned to be enrolled based on their age and health status (2\u201317-year-old children at increased risk of pneumococcal infection or healthy children) and on their priming status (primed children, i.e. previously vaccinated with a pneumococcal vaccine [at least one dose of a PCV more than 2 months before enrolment, or PPSV23 more than 2 years and less than 5 years before enrolment], and unprimed children, i.e. not previously vaccinated with any pneumococcal vaccine).",
            "startOffset": 25986,
            "title": "Study design and population"
        },
        {
            "endOffset": 25391,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "Since its licensure in 2008, it has been implemented in many NIPs, including for high-risk groups.",
            "startOffset": 25293,
            "title": "Background"
        }
    ],
    "docId": "S0264410X17311271",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "leszek.szenborn@umed.wroc.pl",
                "first": "L.",
                "initial": "L.",
                "last": "Szenborn"
            },
            {
                "email": "i.v.osipova@gmail.com",
                "first": "I. V.",
                "initial": "I.V.",
                "last": "Osipova"
            },
            {
                "email": "hanna.czajka@onet.pl",
                "first": "H.",
                "initial": "H.",
                "last": "Czajka"
            },
            {
                "email": "kharit-s@mail.ru",
                "first": "S. M.",
                "initial": "S.M.",
                "last": "Kharit"
            },
            {
                "email": "tjackowska@cmkp.edu.pl",
                "first": "T.",
                "initial": "T.",
                "last": "Jackowska"
            },
            {
                "email": "nancy.a.francois@gsk.com",
                "first": "N.",
                "initial": "N.",
                "last": "Fran\u00e7ois"
            },
            {
                "email": "Ahsan.M.Habib@gsk.com",
                "first": "M. A.",
                "initial": "M.A.",
                "last": "Habib"
            },
            {
                "email": "Dorota.D.Borys@gsk.com",
                "first": "D.",
                "initial": "D.",
                "last": "Borys"
            }
        ],
        "doi": "10.1016/j.vaccine.2017.08.039",
        "firstpage": "5331",
        "issn": "0264410X",
        "keywords": [
            "Asplenia",
            "Immunogenicity",
            "Pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)",
            "Safety",
            "Splenic dysfunction"
        ],
        "lastpage": "5338",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Immunogenicity, safety and reactogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in 2\u201317-year-old children with asplenia or splenic dysfunction: A phase 3 study"
    }
}